Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 36.10B | 32.69B | 34.22B | 33.63B | 36.41B | 39.91B |
Gross Profit | 35.65B | 0.00 | 33.95B | 33.63B | 36.41B | 39.91B |
EBITDA | -15.49B | 2.67B | -22.02B | -3.62B | 5.63B | 0.00 |
Net Income | -23.86B | 1.56B | -23.46B | -7.08B | 2.58B | -3.18B |
Balance Sheet | ||||||
Total Assets | 2.69T | 2.48T | 2.68T | 2.66T | 2.70T | 2.66T |
Cash, Cash Equivalents and Short-Term Investments | 236.38B | 0.00 | 358.62B | 222.27B | 224.83B | 203.94B |
Total Debt | 108.97B | 82.93B | 128.76B | 68.92B | 82.99B | 50.90B |
Total Liabilities | 108.97B | 2.39T | 2.60T | 68.92B | 2.60T | 2.55T |
Stockholders Equity | 99.66B | 82.47B | 83.39B | 77.50B | 100.67B | 116.20B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 29.99B | -8.08B | -21.38B | 27.98B | 95.03B |
Operating Cash Flow | 0.00 | 30.42B | -5.35B | -19.97B | 28.96B | 96.88B |
Investing Cash Flow | 0.00 | -6.87B | 129.91B | 19.55B | -7.98B | -84.95B |
Financing Cash Flow | 0.00 | -213.89B | 19.64B | -656.00M | -698.00M | 2.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥76.67B | 7.44 | 2.76% | 25.33% | 5.53% | ||
74 Outperform | ¥381.10B | 10.88 | 4.96% | 2.42% | 8.46% | 46.91% | |
74 Outperform | $6.61T | 15.77 | 4.73% | 3.14% | -14.57% | 16.03% | |
70 Outperform | ¥1.46T | 11.22 | 2.49% | -6.70% | 58.89% | ||
67 Neutral | ¥836.32B | 13.01 | 9.24% | 3.02% | 7.93% | 10.80% | |
60 Neutral | $1.27T | 14.65 | 6.86% | 2.46% | 13.73% | 28.01% | |
41 Neutral | ¥10.08B | 5.74 | 1.27% | 2.20% | ― |